FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103239091> ?p ?o ?g. }

• W2103239091 endingPage "1703" @default.
• W2103239091 startingPage "1695" @default.
• W2103239091 abstract "Background Diabetic foot infections are a common and serious problem, yet few randomised trials of adequate quality have compared the efficacy of the various antibiotic regimens available for their treatment. Our aim was to assess the efficacy and safety of ertapenem versus piperacillin/tazobactam for foot infections. Methods We did a randomised, double-blinded, multicentre trial in adults (n=586) with diabetes and a foot infection classified as moderate-to-severe and requiring intravenous antibiotics. We assigned patients intravenous ertapenem (1 g daily; n=295) or piperacillin/tazobactam (3·375 g every 6 h; n=291) given for a minimum of 5 days, after which oral amoxicillin/clavulanic acid (875/125 mg every 12 h) could be given for up to 23 days. Investigators retained the option to administer vancomycin to patients in either group to ensure adequate coverage for potentially antibiotic resistant Enterococcus spp and meticillin-resistant Staphylococcus aureus (MRSA). Our primary outcome was the proportion of patients with a favourable clinical response (cure or improvement) on the day that intravenous antibiotic was discontinued. Analyses were by an evaluable-patient only approach. This study is registered with ClinicalTrials.gov, number NCT00229112. Findings Of the 576 patients treated, 445 were available for assessment at the end of intravenous therapy. Both baseline characteristics and favourable clinical response rates were similar for the 226 who received ertapenem and the 219 who received piperacillin/tazobactam (94% vs 92%, respectively; between treatment difference 1·9%, 95% CI −2·9 to 6·9). Rates of favourable microbiological responses (eradication rates and clinical outcomes, by pathogen) and adverse events did not differ between groups. Interpretation Clinical and microbiological outcomes for patients treated with ertapenem were equivalent to those for patients treated with piperacillin/tazobactam, suggesting that this once-daily antibiotic should be considered for parenteral therapy of diabetic foot infections, when deemed appropriate." @default.
• W2103239091 created "2016-06-24" @default.
• W2103239091 creator A5020716687 @default.
• W2103239091 creator A5034035627 @default.
• W2103239091 creator A5051728755 @default.
• W2103239091 creator A5053319026 @default.
• W2103239091 creator A5063750603 @default.
• W2103239091 creator A5086288192 @default.
• W2103239091 date "2005-11-01" @default.
• W2103239091 modified "2023-10-18" @default.
• W2103239091 title "Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial" @default.
• W2103239091 cites W10223341 @default.
• W2103239091 cites W1964004587 @default.
• W2103239091 cites W1968645629 @default.
• W2103239091 cites W1968984743 @default.
• W2103239091 cites W1971266017 @default.
• W2103239091 cites W2000696525 @default.
• W2103239091 cites W2002917627 @default.
• W2103239091 cites W2014420792 @default.
• W2103239091 cites W2017237295 @default.
• W2103239091 cites W2023647440 @default.
• W2103239091 cites W2029449544 @default.
• W2103239091 cites W2037186376 @default.
• W2103239091 cites W2046279374 @default.
• W2103239091 cites W2062975716 @default.
• W2103239091 cites W2075996160 @default.
• W2103239091 cites W2084025044 @default.
• W2103239091 cites W2092363657 @default.
• W2103239091 cites W2092699074 @default.
• W2103239091 cites W2097209038 @default.
• W2103239091 cites W2098329780 @default.
• W2103239091 cites W2098468251 @default.
• W2103239091 cites W2099207046 @default.
• W2103239091 cites W2101537144 @default.
• W2103239091 cites W2102697430 @default.
• W2103239091 cites W2114114837 @default.
• W2103239091 cites W2120245014 @default.
• W2103239091 cites W2122633654 @default.
• W2103239091 cites W2124032639 @default.
• W2103239091 cites W2127380564 @default.
• W2103239091 cites W2145025407 @default.
• W2103239091 cites W2149211904 @default.
• W2103239091 cites W2157698097 @default.
• W2103239091 cites W2161870658 @default.
• W2103239091 cites W2170466541 @default.
• W2103239091 cites W2340455113 @default.
• W2103239091 cites W2412349360 @default.
• W2103239091 cites W2799650017 @default.
• W2103239091 cites W4294847645 @default.
• W2103239091 doi "https://doi.org/10.1016/s0140-6736(05)67694-5" @default.
• W2103239091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16291062" @default.
• W2103239091 hasPublicationYear "2005" @default.
• W2103239091 type Work @default.
• W2103239091 sameAs 2103239091 @default.
• W2103239091 citedByCount "233" @default.
• W2103239091 countsByYear W21032390912012 @default.
• W2103239091 countsByYear W21032390912013 @default.
• W2103239091 countsByYear W21032390912014 @default.
• W2103239091 countsByYear W21032390912015 @default.
• W2103239091 countsByYear W21032390912016 @default.
• W2103239091 countsByYear W21032390912017 @default.
• W2103239091 countsByYear W21032390912018 @default.
• W2103239091 countsByYear W21032390912019 @default.
• W2103239091 countsByYear W21032390912020 @default.
• W2103239091 countsByYear W21032390912021 @default.
• W2103239091 countsByYear W21032390912022 @default.
• W2103239091 countsByYear W21032390912023 @default.
• W2103239091 crossrefType "journal-article" @default.
• W2103239091 hasAuthorship W2103239091A5020716687 @default.
• W2103239091 hasAuthorship W2103239091A5034035627 @default.
• W2103239091 hasAuthorship W2103239091A5051728755 @default.
• W2103239091 hasAuthorship W2103239091A5053319026 @default.
• W2103239091 hasAuthorship W2103239091A5063750603 @default.
• W2103239091 hasAuthorship W2103239091A5086288192 @default.
• W2103239091 hasConcept C126322002 @default.
• W2103239091 hasConcept C134018914 @default.
• W2103239091 hasConcept C141071460 @default.
• W2103239091 hasConcept C2777637488 @default.
• W2103239091 hasConcept C2777858829 @default.
• W2103239091 hasConcept C2777858937 @default.
• W2103239091 hasConcept C2778193466 @default.
• W2103239091 hasConcept C2778266534 @default.
• W2103239091 hasConcept C2778368673 @default.
• W2103239091 hasConcept C2779375183 @default.
• W2103239091 hasConcept C2779454058 @default.
• W2103239091 hasConcept C2779631663 @default.
• W2103239091 hasConcept C2779708577 @default.
• W2103239091 hasConcept C501593827 @default.
• W2103239091 hasConcept C523546767 @default.
• W2103239091 hasConcept C54355233 @default.
• W2103239091 hasConcept C555293320 @default.
• W2103239091 hasConcept C71924100 @default.
• W2103239091 hasConcept C86803240 @default.
• W2103239091 hasConcept C89423630 @default.
• W2103239091 hasConcept C94665300 @default.
• W2103239091 hasConceptScore W2103239091C126322002 @default.
• W2103239091 hasConceptScore W2103239091C134018914 @default.
• W2103239091 hasConceptScore W2103239091C141071460 @default.

• next